UK markets closed

INZY Jul 2024 2.500 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
1.60000.0000 (0.00%)
As of 02:08PM EDT. Market open.
Full screen
Previous close1.6000
Open4.0000
Bid0.0000
Ask4.1000
Strike2.50
Expiry date2024-07-19
Day's range1.6000 - 4.0000
Contract rangeN/A
Volume13
Open interest4
  • Insider Monkey

    Why Did Inozyme Pharma, Inc. (INZY) Get a Strong Buy Rating from Analysts?

    We recently compiled a list of the 10 Best Biotech Penny Stocks to Buy Now. In this article, we are going to take a look at where Inozyme Pharma, Inc. (NASDAQ:INZY) stands against the other biotech penny stocks. Biotech Stocks in 2024: Growth Prospects, Key Players, and Investment Opportunities In 2024, the healthcare industry has […]

  • GlobeNewswire

    Inozyme Pharma Announces Presentation and Sponsored Symposium at the 11th International Conference on Children’s Bone Health (ICCBH)

    Results from a radiographic study describing skeletal features of pediatric patients with ENPP1 Deficiency will be presentedBOSTON, June 21, 2024 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) (“the Company” or “Inozyme”), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of pathologic mineralization and intimal proliferation, today announced a data presentation and sponsored symposium at the 11th International Conference on Children

  • GlobeNewswire

    Inozyme Pharma to Present at the Jefferies Global Healthcare Conference

    BOSTON, May 30, 2024 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) (“the Company” or “Inozyme”), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of pathologic mineralization and intimal proliferation, today announced Doug Treco, Ph.D., CEO and Chairman of Inozyme, will present at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 from 12:30-12:55 pm ET. A live webcast of the presentation can be accessed from the